Evommune, Inc. share price logo

Evommune, Inc.

NYSE: EVMN

Small Cap

$22.62

-0.59

(-2.54%)

as on

Evommune, Inc. Stock Performance

as on May 13, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $22.34
    $23.34
    downward going graph

    1.24%

    Downside

    3.18%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Evommune, Inc. share price movements today

Previous Close
$23.21
Open
$23.14
Volume
404.9K
Day's Low - High
$22.34 - $23.34

Evommune, Inc. Historical Returns

1 Month Return
-9.02 %
3 Month Return
-16.75 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Evommune, Inc. Stock Fundamentals & Key Indicators

Check Evommune, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$825.5M

EPS (TTM)

-2.7475

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-44.95%

Evommune, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Evommune, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Evommune, Inc. image
Evommune, Inc.
NA$825.5MNANA0.00%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$39.4B113.59%74.1312.55%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$32.2BNA70.468.94%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$109.1B104.61%25.5135.51%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$74.9B40.55%17.4529.65%

Indian Investors' Interest in Evommune, Inc. Stock

Search interest for Evommune, Inc. Stock has decreased by -30% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-30% versus previous 30 day period

Evommune, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Sep 2024
Dec 2024
Mar 2025
Sep 2025
Dec 2025
Total Revenue
7
-
-
3
10
-
Gross Profit
6
-
-
2
9
0
Operating Income
-3
-16
-18
-15
-13
-29
EBITDA
-2
-
-18
-14
-12
-29
Interest Expense
0
-
-
0
-
-
Depreciation
-
0
0
-
0
0
Income Before Tax
-2
-15
-18
-14
-12
-28
Income Tax Expense
-
-
-
-
-
-
Net Income
-2
-15
-18
-14
-12
-28
Net Profit Margin
-39.77%
0.00%
0.00%
-485.23%
-124.75%
0.00%

Evommune, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2023
Dec 2024
Dec 2025
Total Revenue
5
7
13
Gross Profit
4
5
11
Operating Income
-37
-70
-81
EBITDA
-32
-65
-79
Interest Expense
0
0
0
Depreciation
-
-
1
Income Before Tax
-34
-66
-68
Income Tax Expense
-
-
-
Net Income
-34
-66
-68
Net Profit Margin
-681.06%
-954.40%
-529.77%

Evommune, Inc. Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-27
-15
-18
-14
-13
-12
-28
-21
Operating Cash Flow
-8
-26
-22
-23
-26
-9
-16
-27
Investing Cash Flow
10
-
-11
13
18
-23
-122
-85
Financing Cash Flow
0
0
24
0
64
0
156
117
Change in Cash
-
-16
-1
5
56
-35
17
4

Evommune, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2024
Dec 2025
Net Income
-66
-68
Operating Cash Flow
-58
-76
Investing Cash Flow
-3
-115
Financing Cash Flow
49
220
Change in Cash
-12
27

Insights on Evommune, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, EVMN stock has moved down by -14.1%

About Evommune, Inc.

Evommune, Inc. operates as a clinical-stage biotechnology company in the United States. The company develops therapies that target key drivers of chronic inflammatory diseases, with initial clinical development programs focusing on chronic spontaneous urticaria, atopic dermatitis, and ulcerative colitis. Its products include EVO756 for the treatment of CSU and AD; and EVO301 for the treatment of AD and UC. The company was incorporated in 2020 and is based in Palo Alto, California.
OrganisationEvommune, Inc.
Headquarters1841 Page Mill Road, Palo Alto, CA, United States, 94304
IndustryBiotechnology
CEOMr. Luis C. Pena
E-voting on sharesClick here to vote

Key Management of Evommune, Inc.

Name

Title

Mr. Luis C. Pena

Founder, President, CEO & Director

Mr. Gregory S. Moss Esq.

Chief Business & Legal Officer, Corporate Secretary and Chief Compliance Officer

Dr. Eugene Andrew Bauer M.D.

Co-Founder, Chief Medical Officer & Director

Dr. Lou Sehl Ph.D.

Senior Vice President of Technical Operations

Mr. J. Mark Jackson M.D.

Senior Vice President of Clinical Development

Mr. Kyle Carver CPA, M.B.A.

Chief Financial Officer

Dr. Jeegar Patel Ph.D.

Chief Scientific Officer

Ms. Janice Drew M.P.H.

Chief of Development Operations

Dr. Daniel J. Burge M.d.

Senior Vice President of Clinical Development

FAQs

What is Evommune, Inc. share price today?

Evommune, Inc. share price today is $22.62 as on at the close of the market. Evommune, Inc. share today touched a day high of $23.34 and a low of $22.34.

What is the 52 week high and 52 week low for Evommune, Inc. share?

Evommune, Inc. share touched a 52 week high of $ on and a 52 week low of $ on . Evommune, Inc. stock price today i.e. is closed at $22.62,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Evommune, Inc.'s market capitalisation today?

Evommune, Inc. market capitalisation is $0.00T as on .

How to invest in Evommune, Inc. Stock (EVMN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Evommune, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Evommune, Inc. Shares that will get you 0.0663 shares as per Evommune, Inc. share price of $22.62 per share as on May 13, 2026 at 1:29 am IST.

What is the minimum amount required to buy Evommune, Inc. Stock (EVMN) from India?

Indian investors can start investing in Evommune, Inc. (EVMN) shares with as little as ₹95.618 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹956.18 in Evommune, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Evommune, Inc. share’s latest price of $22.62 as on May 13, 2026 at 1:29 am IST, you will get 0.4421 shares of Evommune, Inc.. Learn more about fractional shares .